Biogen Inc (BIIB)
120.17 +1.05 (+0.88%) 04/29/25 [NASDAQ]
118.92 x 100 121.20 x 100
Realtime by (Cboe BZX)
118.92 x 100 121.20 x 100
Realtime - - (-) -
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | BIIB | ONC | GMAB | ||
| Company | Biogen Inc | Beigene Ltd ADR | Genmab A/S ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 117.96 | 249.09 | 21.04 | ||
| High | 121.17 | 250.29 | 21.08 | ||
| Low | 116.63 | 246.04 | 20.75 | ||
| Last | 120.17 | 249.77 | 20.79 | ||
| Change | +1.05 | +0.31 | +0.16 | ||
| % Change | +0.88% | +0.12% | +0.78% | ||
| Volume | 1,003,300 | 321,200 | 1,230,900 | ||
| 20-Day Average Volume | 1,806,510 | 595,225 | 1,573,070 | ||
| Previous Close | 119.12 | 249.46 | 20.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 120.03 | 239.79 | 19.42 | ||
| 20-Day Raw Stochastic | 37.13% | 60.80% | 92.57% | ||
| 20-Day Relative Strength | 41.44% | 52.42% | 55.32% | ||
| Weighted Alpha | -47.33 | +54.60 | -27.63 | ||
| Today's Opinion | 88% Sell | 80% Buy | 48% Sell | ||
| Previous Opinion | 100% Sell | 80% Buy | 72% Sell | ||
| Last Month's Opinion | 72% Sell | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 04/22/25 | -1.19% since 04/22/25 | +2.57% since 04/22/25 | ||
| Low | 116.63 on 04/29/25 | 244.40 on 04/25/25 | 20.02 on 04/23/25 | ||
| High | 121.75 on 04/23/25 | 259.98 on 04/24/25 | 21.08 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | -13.15% since 03/28/25 | -6.59% since 03/28/25 | +4.47% since 03/28/25 | ||
| Low | 110.04 on 04/09/25 | 196.45 on 04/09/25 | 17.24 on 04/09/25 | ||
| High | 138.00 on 03/31/25 | 284.15 on 04/01/25 | 21.08 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | -16.79% since 01/29/25 | +10.17% since 01/29/25 | +4.74% since 01/29/25 | ||
| Low | 110.04 on 04/09/25 | 196.45 on 04/09/25 | 17.24 on 04/09/25 | ||
| High | 157.09 on 03/10/25 | 287.88 on 02/27/25 | 24.33 on 03/07/25 | ||
| 6-Month | |||||
| %Chg | -34.50% since 10/29/24 | +15.35% since 10/29/24 | -10.08% since 10/29/24 | ||
| Low | 110.04 on 04/09/25 | 170.99 on 12/19/24 | 17.24 on 04/09/25 | ||
| High | 185.00 on 10/30/24 | 287.88 on 02/27/25 | 24.33 on 03/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,589,884 | 24,705,002 | 13,330,631 | ||
| Shares Outstanding, K | 146,375 | 98,911 | 641,204 | ||
| Annual Sales | 9,675,900,000 | 3,810,240,000 | 3,121,270,000 | ||
| Annual Net Income | 1,632,200,000 | -644,790,000 | 1,137,380,000 | ||
| Last Quarter Sales | 2,454,700,000 | 1,127,820,000 | 921,940,000 | ||
| Last Quarter Net Income | 266,700,000 | -151,880,000 | 554,680,000 | ||
| 60-Month Beta | 0.06 | 0.49 | 1.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.44 on 02/12/25 | -1.43 on 02/27/25 | 0.57 on 02/12/25 | ||
| Latest Earnings Date | 05/01/25 | 05/07/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 7.23 | 0.00 | 16.64 | ||